Leadless Pacemaker Atrial Detection via Endocardial Acceleration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Leadless cardiac pacemakers implanted in the ventricle lack the capability to detect atrial activity, which is essential for synchronized pacing with the sinus rhythm, especially during physical activity, as they do not have an atrial electrode to collect atrial signals, leading to sub-optimal pacing rates.

Innovation Solution

A leadless cardiac pacemaker equipped with an endocardial acceleration sensor that detects atrial activity by analyzing the EA signal, identifying the EA4 component associated with atrial contraction, allowing for the determination of an atrioventricular delay and adjustment of pacing rates without the need for an atrial electrode.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If a leadless capsule is implanted in the ventricle for single chamber stimulation, then the device complexity is reduced and implantation is simplified, but the capability to detect atrial activity is lost

Engineering Contradiction:
Improvedevice complexityVSAvoiddetection capability
Core Design Contradiction:
Device complexityVSAdaptability or versatility

Solution Approach 1:

The patent applies multi-functionality by enabling the ventricular leadless capsule to perform both ventricular pacing and atrial activity detection. The capsule uses its ventricular electrodes to detect far-field atrial signals, allowing a single device to provide both ventricular stimulation and atrial sensing capabilities that would traditionally require separate atrial electrodes or leads.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent uses the ventricular myocardium and blood pool as an intermediary medium to transmit atrial electrical signals to the ventricular electrodes. The atrial depolarization waves propagate through the cardiac tissue and blood, allowing the ventricular capsule electrodes to detect atrial activity indirectly through far-field signal detection.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Device complexity

If atrial activity is detected using far-field signals from ventricular electrodes, then atrial detection capability is achieved without additional atrial electrodes, but signal quality and reliability deteriorate

Engineering Contradiction:
Improvedevice complexityVSAvoidsignal quality
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent implements feedback mechanisms through signal filtering and processing algorithms that continuously analyze the electrogram signals from ventricular electrodes. The system uses filtering to distinguish far-field atrial signals from near-field ventricular signals, and employs detection algorithms to reliably identify atrial depolarization events despite the lower signal quality of far-field detection.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces the mechanical/electrical system of direct atrial electrode contact with a signal processing system. Instead of physically placing electrodes in the atrium, the invention uses electronic filtering and signal analysis to extract atrial activity information from ventricular electrode recordings, substituting physical proximity with computational detection.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Device complexity

If ventricular pacing is performed without atrial activity detection, then the pacing system is simpler, but pacing synchronization with sinus rhythm is lost

Engineering Contradiction:
Improvedevice complexityVSAvoidpacing synchronization
Core Design Contradiction:
Device complexityVSEase of operation

Solution Approach 1:

The patent enables the ventricular pacemaker to perform dual functions: ventricular pacing and atrial activity detection. By processing far-field signals from ventricular electrodes, the device can determine atrial depolarization timing and synchronize ventricular pacing accordingly, providing VDD-mode functionality without requiring separate atrial electrodes.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent uses far-field electrical signal propagation through cardiac tissue and blood as an intermediary to transmit atrial timing information to the ventricular pacemaker. This allows the device to detect atrial events and calculate appropriate atrioventricular delays for synchronized pacing without direct atrial electrode contact.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables reliable detection of atrial activity, allowing for synchronized pacing and adaptation to the patient's intrinsic rhythm, improving pacing efficiency and accuracy without the need for an atrial electrode, thus overcoming the limitations of existing leadless pacemakers.

Implementation Method 1

via an acceleration sensor, deliver an endocardial acceleration EA signal, representative of the cyclic contractions of the myocardium

Methodology Applied
Scientific EffectPiezoelectric effect: Piezoelectric Effect

Data Source

PatentUS9884193B2Pacemaker with detection of atrial activity without collection of atrial electrical activity
Publication Date: 2018.02.06 SORIN CRM
  • US9884193B2 patent drawing
  • US9884193B2 patent drawing
  • US9884193B2 patent drawing

AI summary

The invention relates to an active implantable pacemaker. The device analyzes a ventricular electrogram signal (EGM) and is able to recognize, in a search window, an EA4 component of endocardial acceleration (EA) associated with atrial activity. In the presence of atrioventricular conduction, the search window is determined based on the temporal position of the EA1 and/or EA2 components of the EA signal. In the absence of atrioventricular conduction, a delay is counted from a paced ventricular event and applied to mask the EA1 and/or EA2 components in the EA signal, and the window for research of the EA4 component follows the masking delay. In the presence of a confirmed EA4 component, an atrioventricular delay is applied, counted from the EA4 component, and in the opposite case a predetermined escape interval is applied, counted from the last stimulated ventricular event.